Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 105 (1) , 37-54
- https://doi.org/10.1016/0041-008x(90)90357-z
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissuesToxicology and Applied Pharmacology, 1989
- Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessmentToxicology Letters, 1988
- Physiologically based pharmacokinetics and the risk assessment process for methylene chlorideToxicology and Applied Pharmacology, 1987
- A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humansToxicology and Applied Pharmacology, 1984
- Differentiation of the mechanisms of oncogenicity of 1,4-dioxane and 1,3-hexachlorobutadiene in the ratToxicology and Applied Pharmacology, 1981
- Identification of β-hydroxyethoxyacetic acid as the major urinary metabolite of 1,4-dioxane in the ratToxicology and Applied Pharmacology, 1976
- 1,4-Dioxane. I. Results of a 2-year ingestion study in ratsToxicology and Applied Pharmacology, 1974
- Carcinogenesis bioassay of chlorinated dibenzodioxins and related chemicals.Environmental Health Perspectives, 1973
- Dose-response and ultrastructural alterations in dioxane carcinogenesis.: Influence of methylcholanthrene on acute toxicityPublished by Elsevier ,1973
- Induction of Carcinomas in the Nasal Cavity of Rats by DioxaneBritish Journal of Cancer, 1970